Global Alternative to Antibiotics Market Growth 2021-2026

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Years Considered
• 1.3 Research Objectives
• 1.4 Market Research Methodology
• 1.5 Research Process and Data Source
• 1.6 Economic Indicators
• 1.7 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Alternative to Antibiotics Consumption 2016-2026
  • 2.1.2 Alternative to Antibiotics Consumption CAGR by Region
• 2.2 Alternative to Antibiotics Segment by Type
  • 2.2.1 Antimicrobial Proteins
  • 2.2.2 Bacteriophages
  • 2.2.3 Probiotics
  • 2.2.4 Other
• 2.3 Alternative to Antibiotics Sales by Type
  • 2.3.1 Global Alternative to Antibiotics Sales Market Share by Type (2016-2021)
  • 2.3.2 Global Alternative to Antibiotics Revenue and Market Share by Type (2016-2021)
  • 2.3.3 Global Alternative to Antibiotics Sale Price by Type (2016-2021)
• 2.4 Alternative to Antibiotics Segment by Application
  • 2.4.1 Food & Beverage
  • 2.4.2 Drugs
  • 2.4.3 Dietary Supplements
• 2.5 Alternative to Antibiotics Sales by Application
  • 2.5.1 Global Alternative to Antibiotics Sale Market Share by Application (2016-2021)
  • 2.5.2 Global Alternative to Antibiotics Revenue and Market Share by Application (2016-2021)
  • 2.5.3 Global Alternative to Antibiotics Sale Price by Application (2016-2021)

3 Global Alternative to Antibiotics by Company

• 3.1 Global Alternative to Antibiotics Sales Market Share by Company
  • 3.1.1 Global Alternative to Antibiotics Sales by Company (2019-2021)
  • 3.1.2 Global Alternative to Antibiotics Sales Market Share by Company (2019-2021)
• 3.2 Global Alternative to Antibiotics Revenue Market Share by Company
  • 3.2.1 Global Alternative to Antibiotics Revenue by Company (2019-2021)
  • 3.2.2 Global Alternative to Antibiotics Revenue Market Share by Company (2019-2021)
• 3.3 Global Alternative to Antibiotics Sale Price by Company
• 3.4 Global Manufacturers Alternative to Antibiotics Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Alternative to Antibiotics Product Location Distribution
  • 3.4.2 Players Alternative to Antibiotics Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Alternative to Antibiotics by Region

• 4.1 Global Alternative to Antibiotics by Region
  • 4.1.1 Global Alternative to Antibiotics Sales by Region
  • 4.1.2 Global Alternative to Antibiotics Revenue by Region
• 4.2 Americas Alternative to Antibiotics Sales Growth
• 4.3 APAC Alternative to Antibiotics Sales Growth
• 4.4 Europe Alternative to Antibiotics Sales Growth
• 4.5 Middle East & Africa Alternative to Antibiotics Sales Growth

5 Americas

• 5.1 Americas Alternative to Antibiotics Sales by Country
  • 5.1.1 Americas Alternative to Antibiotics Sales by Country (2016-2021)
  • 5.1.2 Americas Alternative to Antibiotics Revenue by Country (2016-2021)
• 5.2 Americas Alternative to Antibiotics Sales by Type
• 5.3 Americas Alternative to Antibiotics Sales by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Brazil

6 APAC

• 6.1 APAC Alternative to Antibiotics Sales by Region
  • 6.1.1 APAC Alternative to Antibiotics Sales by Region (2016-2021)
  • 6.1.2 APAC Alternative to Antibiotics Revenue by Region (2016-2021)
• 6.2 APAC Alternative to Antibiotics Sales by Type
• 6.3 APAC Alternative to Antibiotics Sales by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia

7 Europe

• 7.1 Europe Alternative to Antibiotics by Country
  • 7.1.1 Europe Alternative to Antibiotics Sales by Country (2016-2021)
  • 7.1.2 Europe Alternative to Antibiotics Revenue by Country (2016-2021)
• 7.2 Europe Alternative to Antibiotics Sales by Type
• 7.3 Europe Alternative to Antibiotics Sales by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia

8 Middle East & Africa

• 8.1 Middle East & Africa Alternative to Antibiotics by Country
  • 8.1.1 Middle East & Africa Alternative to Antibiotics Sales by Country (2016-2021)
  • 8.1.2 Middle East & Africa Alternative to Antibiotics Revenue by Country (2016-2021)
• 8.2 Middle East & Africa Alternative to Antibiotics Sales by Type
• 8.3 Middle East & Africa Alternative to Antibiotics Sales by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Country

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Alternative to Antibiotics Distributors
• 10.3 Alternative to Antibiotics Customer

11 Global Alternative to Antibiotics Market Forecast

• 11.1 Global Alternative to Antibiotics Forecast by Region
  • 11.1.1 Global Alternative to Antibiotics Forecast by Regions (2021-2026)
  • 11.2.2 Global Alternative to Antibiotics Revenue Forecast by Regions (2021-2026)
• 11.2 Americas Forecast by Country
• 11.3 APAC Forecast by Region
• 11.4 Europe Forecast by Country
• 11.5 Middle East & Africa Forecast by Country
• 11.6 Global Alternative to Antibiotics Forecast by Type
• 11.7 Global Alternative to Antibiotics Forecast by Application

12 Key Players Analysis

• 12.1 DSM
  • 12.1.1 DSM Company Information
  • 12.1.2 DSM Alternative to Antibiotics Product Offered
  • 12.1.3 DSM Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.1.4 DSM Main Business Overview
  • 12.1.5 DSM Latest Developments
• 12.2 DuPont(Danisco)
  • 12.2.1 DuPont(Danisco) Company Information
  • 12.2.2 DuPont(Danisco) Alternative to Antibiotics Product Offered
  • 12.2.3 DuPont(Danisco) Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.2.4 DuPont(Danisco) Main Business Overview
  • 12.2.5 DuPont(Danisco) Latest Developments
• 12.3 Chr. Hansen
  • 12.3.1 Chr. Hansen Company Information
  • 12.3.2 Chr. Hansen Alternative to Antibiotics Product Offered
  • 12.3.3 Chr. Hansen Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.3.4 Chr. Hansen Main Business Overview
  • 12.3.5 Chr. Hansen Latest Developments
• 12.4 Lallemand
  • 12.4.1 Lallemand Company Information
  • 12.4.2 Lallemand Alternative to Antibiotics Product Offered
  • 12.4.3 Lallemand Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.4.4 Lallemand Main Business Overview
  • 12.4.5 Lallemand Latest Developments
• 12.5 China-Biotics
  • 12.5.1 China-Biotics Company Information
  • 12.5.2 China-Biotics Alternative to Antibiotics Product Offered
  • 12.5.3 China-Biotics Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.5.4 China-Biotics Main Business Overview
  • 12.5.5 China-Biotics Latest Developments
• 12.6 Nestle
  • 12.6.1 Nestle Company Information
  • 12.6.2 Nestle Alternative to Antibiotics Product Offered
  • 12.6.3 Nestle Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.6.4 Nestle Main Business Overview
  • 12.6.5 Nestle Latest Developments
• 12.7 Danone
  • 12.7.1 Danone Company Information
  • 12.7.2 Danone Alternative to Antibiotics Product Offered
  • 12.7.3 Danone Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.7.4 Danone Main Business Overview
  • 12.7.5 Danone Latest Developments
• 12.8 Probi
  • 12.8.1 Probi Company Information
  • 12.8.2 Probi Alternative to Antibiotics Product Offered
  • 12.8.3 Probi Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.8.4 Probi Main Business Overview
  • 12.8.5 Probi Latest Developments
• 12.9 BioGaia
  • 12.9.1 BioGaia Company Information
  • 12.9.2 BioGaia Alternative to Antibiotics Product Offered
  • 12.9.3 BioGaia Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.9.4 BioGaia Main Business Overview
  • 12.9.5 BioGaia Latest Developments
• 12.10 Yakult
  • 12.10.1 Yakult Company Information
  • 12.10.2 Yakult Alternative to Antibiotics Product Offered
  • 12.10.3 Yakult Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.10.4 Yakult Main Business Overview
  • 12.10.5 Yakult Latest Developments
• 12.11 Novozymes
  • 12.11.1 Novozymes Company Information
  • 12.11.2 Novozymes Alternative to Antibiotics Product Offered
  • 12.11.3 Novozymes Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.11.4 Novozymes Main Business Overview
  • 12.11.5 Novozymes Latest Developments
• 12.12 Valio
  • 12.12.1 Valio Company Information
  • 12.12.2 Valio Alternative to Antibiotics Product Offered
  • 12.12.3 Valio Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.12.4 Valio Main Business Overview
  • 12.12.5 Valio Latest Developments
• 12.13 Glory Biotech
  • 12.13.1 Glory Biotech Company Information
  • 12.13.2 Glory Biotech Alternative to Antibiotics Product Offered
  • 12.13.3 Glory Biotech Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.13.4 Glory Biotech Main Business Overview